111 related articles for article (PubMed ID: 31655866)
1. Identification of a novel large EPCAM-MSH2 duplication, concurrently with LOHs in chromosome 20 and X, in a family with Lynch syndrome.
Pirini F; Tedaldi G; Danesi R; Cangini I; Tumedei MM; Ferrari A; Vitali S; De Maio G; Terragna C; Solli V; Tebaldi M; Puccetti M; Zampiga V; Ravegnani M; Ulivi P; Falcini F; Martinelli G; Calistri D
Int J Colorectal Dis; 2019 Nov; 34(11):1999-2002. PubMed ID: 31655866
[TBL] [Abstract][Full Text] [Related]
2. Frequency of rearrangements in Lynch syndrome cases associated with MSH2: characterization of a new deletion involving both EPCAM and the 5' part of MSH2.
Pérez-Cabornero L; Infante Sanz M; Velasco Sampedro E; Lastra Aras E; Acedo Becares A; Miner Pino C; Durán Domínguez M
Cancer Prev Res (Phila); 2011 Oct; 4(10):1556-62. PubMed ID: 21791569
[TBL] [Abstract][Full Text] [Related]
3. Elucidating the molecular basis of MSH2-deficient tumors by combined germline and somatic analysis.
Vargas-Parra GM; González-Acosta M; Thompson BA; Gómez C; Fernández A; Dámaso E; Pons T; Morak M; Del Valle J; Iglesias S; Velasco À; Solanes A; Sanjuan X; Padilla N; de la Cruz X; Valencia A; Holinski-Feder E; Brunet J; Feliubadaló L; Lázaro C; Navarro M; Pineda M; Capellá G
Int J Cancer; 2017 Oct; 141(7):1365-1380. PubMed ID: 28577310
[TBL] [Abstract][Full Text] [Related]
4. Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome.
Dillon JL; Gonzalez JL; DeMars L; Bloch KJ; Tafe LJ
Hum Pathol; 2017 Dec; 70():121-128. PubMed ID: 29107668
[TBL] [Abstract][Full Text] [Related]
5. Rare germline alterations in cancer-related genes associated with the risk of multiple primary tumor development.
Villacis RAR; Basso TR; Canto LM; Pinheiro M; Santiago KM; Giacomazzi J; de Paula CAA; Carraro DM; Ashton-Prolla P; Achatz MI; Rogatto SR
J Mol Med (Berl); 2017 May; 95(5):523-533. PubMed ID: 28093616
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of epithelial cell adhesion molecule expression in the algorithmic approach to Lynch syndrome identification.
Musulen E; Blanco I; Carrato C; Fernandez-Figueras MT; Pineda M; Capella G; Ariza A
Hum Pathol; 2013 Mar; 44(3):412-6. PubMed ID: 23026194
[TBL] [Abstract][Full Text] [Related]
7. EPCAM germline and somatic rearrangements in Lynch syndrome: identification of a novel 3'EPCAM deletion.
Spaepen M; Neven E; Sagaert X; De Hertogh G; Beert E; Wimmer K; Matthijs G; Legius E; Brems H
Genes Chromosomes Cancer; 2013 Sep; 52(9):845-54. PubMed ID: 23801599
[TBL] [Abstract][Full Text] [Related]
8. Toward a better definition of EPCAM deletions in Lynch Syndrome: Report of new variants in Italy and the associated molecular phenotype.
Cini G; Quaia M; Canzonieri V; Fornasarig M; Maestro R; Morabito A; D'Elia AV; Urso ED; Mammi I; Viel A
Mol Genet Genomic Med; 2019 May; 7(5):e587. PubMed ID: 30916491
[TBL] [Abstract][Full Text] [Related]
9. Inversion of exons 1-7 of the MSH2 gene is a frequent cause of unexplained Lynch syndrome in one local population.
Rhees J; Arnold M; Boland CR
Fam Cancer; 2014 Jun; 13(2):219-25. PubMed ID: 24114314
[TBL] [Abstract][Full Text] [Related]
10. Analysis of EPCAM protein expression in diagnostics of Lynch syndrome.
Kloor M; Voigt AY; Schackert HK; Schirmacher P; von Knebel Doeberitz M; Bläker H
J Clin Oncol; 2011 Jan; 29(2):223-7. PubMed ID: 21115857
[TBL] [Abstract][Full Text] [Related]
11. Identification of a Japanese Lynch syndrome patient with large deletion in the 3' region of the EPCAM gene.
Eguchi H; Kumamoto K; Suzuki O; Kohda M; Tada Y; Okazaki Y; Ishida H
Jpn J Clin Oncol; 2016 Feb; 46(2):178-84. PubMed ID: 26613680
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel pathogenic MSH2 mutation and new DNA repair genes variants: investigation of a Tunisian Lynch syndrome family with discordant twins.
Jaballah-Gabteni A; Tounsi H; Kabbage M; Hamdi Y; Elouej S; Ben Ayed I; Medhioub M; Mahmoudi M; Dallali H; Yaiche H; Ben Jemii N; Maaloul A; Mezghani N; Abdelhak S; Hamzaoui L; Azzouz M; Boubaker S
J Transl Med; 2019 Jun; 17(1):212. PubMed ID: 31248416
[TBL] [Abstract][Full Text] [Related]
13. Identification of MSH2 inversion of exons 1-7 in clinical evaluation of families with suspected Lynch syndrome.
Mork ME; Rodriguez A; Taggart MW; Rodriguez-Bigas MA; Lynch PM; Bannon SA; You YN; Vilar E
Fam Cancer; 2017 Jul; 16(3):357-361. PubMed ID: 28004223
[TBL] [Abstract][Full Text] [Related]
14. New EPCAM founder deletion in Polish population.
Dymerska D; Gołębiewska K; Kuświk M; Rudnicka H; Scott RJ; Billings R; Pławski A; Boruń P; Siołek M; Kozak-Klonowska B; Szwiec M; Kilar E; Huzarski T; Byrski T; Lubiński J; Kurzawski G
Clin Genet; 2017 Dec; 92(6):649-653. PubMed ID: 28369810
[TBL] [Abstract][Full Text] [Related]
15. The molecular basis of EPCAM expression loss in Lynch syndrome-associated tumors.
Huth C; Kloor M; Voigt AY; Bozukova G; Evers C; Gaspar H; Tariverdian M; Schirmacher P; von Knebel Doeberitz M; Bläker H
Mod Pathol; 2012 Jun; 25(6):911-6. PubMed ID: 22388758
[TBL] [Abstract][Full Text] [Related]
16. First description of mutational analysis of MLH1, MSH2 and MSH6 in Algerian families with suspected Lynch syndrome.
Ziada-Bouchaar H; Sifi K; Filali T; Hammada T; Satta D; Abadi N
Fam Cancer; 2017 Jan; 16(1):57-66. PubMed ID: 27468915
[TBL] [Abstract][Full Text] [Related]
17. Multigene Panel Testing Provides a New Perspective on Lynch Syndrome.
Espenschied CR; LaDuca H; Li S; McFarland R; Gau CL; Hampel H
J Clin Oncol; 2017 Aug; 35(22):2568-2575. PubMed ID: 28514183
[TBL] [Abstract][Full Text] [Related]
18. Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome.
Niessen RC; Hofstra RM; Westers H; Ligtenberg MJ; Kooi K; Jager PO; de Groote ML; Dijkhuizen T; Olderode-Berends MJ; Hollema H; Kleibeuker JH; Sijmons RH
Genes Chromosomes Cancer; 2009 Aug; 48(8):737-44. PubMed ID: 19455606
[TBL] [Abstract][Full Text] [Related]
19. Genetic and genomic basis of the mismatch repair system involved in Lynch syndrome.
Tamura K; Kaneda M; Futagawa M; Takeshita M; Kim S; Nakama M; Kawashita N; Tatsumi-Miyajima J
Int J Clin Oncol; 2019 Sep; 24(9):999-1011. PubMed ID: 31273487
[TBL] [Abstract][Full Text] [Related]
20. Recurrence and variability of germline EPCAM deletions in Lynch syndrome.
Kuiper RP; Vissers LE; Venkatachalam R; Bodmer D; Hoenselaar E; Goossens M; Haufe A; Kamping E; Niessen RC; Hogervorst FB; Gille JJ; Redeker B; Tops CM; van Gijn ME; van den Ouweland AM; Rahner N; Steinke V; Kahl P; Holinski-Feder E; Morak M; Kloor M; Stemmler S; Betz B; Hutter P; Bunyan DJ; Syngal S; Culver JO; Graham T; Chan TL; Nagtegaal ID; van Krieken JH; Schackert HK; Hoogerbrugge N; van Kessel AG; Ligtenberg MJ
Hum Mutat; 2011 Apr; 32(4):407-14. PubMed ID: 21309036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
